News and Trends 21 Jul 2022
Additional funding for trial to study drug targeting lung immunity in elderly patients
Lung immunity in the elderly will be the subject of a controlled clinical trial after receiving clearance to go ahead from Health Canada. Qu Biologics will receive additional funding to…